On this page:Overview Publications Researchers Institutions Open access

PICO Portalanswers from OpenAlex

Chengdu Military General Hospital

InstitutionResearch output, impact & collaborations

Chengdu Military General Hospital is a institution indexed in PICO Portal from OpenAlex.

What is known about Chengdu Military General Hospital?

PICO Portalrecord summary

Chengdu Military General Hospital is a research organisation in Chengdu, CN. OpenAlex records 3,400 works and 112,173 citations for it. 1,242 researchers list it as their most recent affiliation.

How many works does Chengdu Military General Hospital have?

PICO Portalindexed works

Chengdu Military General Hospital has 3,400 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Chengdu Military General Hospital →

How many citations does Chengdu Military General Hospital have?

PICO Portalcitation count

Chengdu Military General Hospital has 112,173 citations in the OpenAlex counts PICO Portal stores.

See the listed works for Chengdu Military General Hospital →

How many researchers are at Chengdu Military General Hospital?

PICO Portalresearcher count

Chengdu Military General Hospital has 1,242 researchers in the PICO Portal index.

See the researchers listed on this page →

What is the average h-index at Chengdu Military General Hospital?

PICO Portalavg h-index

Chengdu Military General Hospital has an average h-index of 3 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Chengdu Military General Hospital?

PICO Portalror

The ROR for Chengdu Military General Hospital is on the source record.

Open the ROR →

What is the OpenAlex record for Chengdu Military General Hospital?

PICO Portalopenalex

The OpenAlex for Chengdu Military General Hospital is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Chengdu Military General Hospital?

PICO Portaltop researchers by citations

Y. Li · Lung Cancer Research Studies

5 works28 citations

What are the most-cited papers on Chengdu Military General Hospital?

PICO Portalmost cited works

Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical Trial

Zhiwei Chen, Lin Wu, Qiming Wang, Yan Yu, Xianling Liu, Rui Ma, Tao Li, Y. Li, Xia Song, Li Lin, Zhao Wei, Qiaoyun Wang, Xiao‐Quan Xu, Shun Lü

Journal of Thoracic Oncology. 202418 Citations

Comparison of totally laparoscopic and laparoscopic-assisted approach in gastrectomy with D2 lymphadenectomy for advanced gastric cancer after neoadjuvant chemotherapy: a retrospective comparative study

Zhenyu Chen, Guangyu Chen, Y. Li, Sha Kou, T C Wang, L Zhang, Yongkuan Cao, Liye Liu

Annals of Surgical Treatment and Research. 20245 CitationsOPEN ACCESS

P33.12 Real-World Prevalence of PD-L1 Expression in Chinese Patients with Advanced or Metastatic NSCLC: Express II Study

Dongmei Lin, Xin Yang, Lili Jiang, W. Wang, Yingyong Hou, Y. Li, Y. Jin, Xiangshan Fan, Weibo Sun, Jae Kwang Yun, P. Li, D. Kuang, L. Zhang, J. Ni, A. Mao, Weiming Tang, Z. Liu, Jiamiao Wang, Shanshan Xiao

Journal of Thoracic Oncology. 20214 CitationsOPEN ACCESS

Patient-Derived Organoids (PDO) As the Potential Model to Predict Treatment Outcome of Rectal Cancer Patients Underwent Neo-Adjuvant Chemoradiotherapy

Ye Yao, Xiaofeng Xu, Long-Shan Yang, Ji Zhu, Juefeng Wan, Lijun Shen, Fan Xia, Guoxiang Fu, Yibin Deng, Mian Pan, Qiang Guo, Xiaojian Gao, Y. Li, Xinxin Rao, Liping Liang, Y. Wang, J. Zhang, H. Zhang, Liwu Zhang, Junjie Peng, S. Cai, Jianjun Gao, Hans Clevers, Zhiwei Zhang, Guoqiang Hua

International Journal of Radiation Oncology*Biology*Physics. 20191 Citations

P47.04 Neuroendocrine Transformation from EGFR-wild type or TKI-naïve Non-Small Cell Lung Cancer: An Under-Recognized Phenomenon?

X. Chu, Yue Zhou, Y. Li, Zhengfei Zhu

Journal of Thoracic Oncology. 20210 CitationsOPEN ACCESS

How much of the research on Chengdu Military General Hospital is open access?

PICO Portalopen access share

60%OPEN ACCESS

Gold

20%

Green

Hybrid

Bronze

40%

Closed

40%